Spinal Analgesia in Labour Pain
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: injecting dexmedetomidine, injecting mixture of bupivacaine fentanyl.
- Who it may be relevant to
- Registry conditions: Labour Analgesia. Basic parameters: 18 years — 40 years · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Egypt
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Effect of Adding Dexmedetomidine to Bupivacain _fentanyl Mixture in Spinal Analgesia for Normal Labour
Overview
To evaluate the efficacy and safety of dexmedetomidine as an adjuvant to bupivacain and fentanyl in spinal Analgesia to decreases pain during normal labour
Detailed description
Effect of adding dexmedetomidine to bupivacain fentanyl mixture in spinal analgesia for normal labour
Interventions
- Drug injecting dexmedetomidine
injecting dexmedetomidine intrathecally during labour pain - Drug injecting mixture of bupivacaine fentanyl
injecting mixture of bupivacaine fentanyl intrathecally
Primary outcome measures
- changes in numeric pain intensity score ( NPSI) maximum 10 minimum 0 [Time frame: baseline]
- duration of sensory blockade [Time frame: 5 minutes after injection of analgesic agents till normal delivery done]
- changes in numeric pain intensity score ( NPIS ) [Time frame: 5 minutes, 10 minutes, 15 minutes, 30 minutes and 45 minintes after injection of analgesic agents]
Eligibility criteria
Inclusion criteria
Age of patint is between 18 and 40 years. gestational age of fetus is more than 37 weeks. singleton viable fetus and cephalic presentation. spontaneous labor with cervix dilation more than 5cm.
Exclusion criteria
Drug allergy. Blood Disease. Infection at site of injection. patient takes anticoagulants. patient has pre-eclampsia ,cardiac disease (NYHA III-IV) or diabetes mellitus type I prior to the pregnancy patients refuse
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Triple blind
- Primary purpose
- Treatment
Study locations
Egypt · 1 center
- Minya — Minya
Identifiers
NCT: NCT07332130 · 1337/11/2024